Fairman, Alexander S <br/><br/>
Characterization and outcomes of reinterventions in Food and Drug Administration-approved versus trial endovascular aneurysm repair devices.  [electronic resource] 

 -  Journal of vascular surgery  04 2018 
 - 1082-1090 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1097-6809 
<br/><br/><label>Standard No.: </label>10.1016/j.jvs.2017.08.058  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Aortic Aneurysm--diagnostic imaging<br/>Blood Vessel Prosthesis<br/>Blood Vessel Prosthesis Implantation--adverse effects<br/>Chi-Square Distribution<br/>Clinical Trials as Topic<br/>Device Approval<br/>Device Removal<br/>Disease-Free Survival<br/>Endovascular Procedures--adverse effects<br/>Female<br/>Hospitals, University<br/>Humans<br/>Kaplan-Meier Estimate<br/>Logistic Models<br/>Male<br/>Middle Aged<br/>Odds Ratio<br/>Postoperative Complications--diagnostic imaging<br/>Proportional Hazards Models<br/>Prosthesis Design<br/>Reoperation--adverse effects<br/>Retrospective Studies<br/>Risk Factors<br/>Stents<br/>Time Factors<br/>Treatment Outcome<br/>United States<br/>United States Food and Drug Administration